Company Update

Prism Medico and Pharmacy Limited has announced its investor complaint status for the quarter ended June 30, 2025. The company reported zero investor complaints, with no pending issues at the start of the quarter, no new complaints received, and all zero complaints resolved.

This excellent track record underscores the company's commitment to strong governance and effective stakeholder management, reflecting well on operational efficiency and investor satisfaction.

This transparency is a key positive for shareholders.